$20.35
Value $5.1B
SBRA and WELL stock compared: price, dividend, valuation and results, from SEC filings.
$20.35
Value $5.1B
$244.65
Value $179B
Sabra Health Care REIT (SBRA) has a market value of $5.1B and Welltower (WELL) $179B. Over the last year, with dividends, SBRA moved +17.5% and WELL +28.0%. The P/E is 71.8 for SBRA and 107.7 for WELL. Dividend yield: SBRA 5.90%, WELL 1.30%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
SBRA$5.1B
WELL$179B
WELL is 35 times SBRA
Revenue, 12 months
SBRA$919M
WELL$13.8B
WELL is 15 times SBRA
Net income, 12 months
SBRA$72M
WELL$1.7B
WELL is 23 times SBRA
Operating margin
SBRA–
WELL–
ROIC
SBRA1.0%
WELL–
P/E
SBRA71.8
WELL107.7
WELL is 1.5 times SBRA
Dividend yield
SBRA5.9%
WELL1.3%
4.6 points apart
5-year return
SBRA+106.9%
WELL+226.1%
119.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
SBRA+106.8%
WELL+226.1%
| Period | SBRAWith dividends | WELLWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +17.5%Price +9.1% | +28.0%Price +26.2% |
| 3 years since November 16, 2023 | +75.3%+20.6% a yearPrice +43.1% | +197.8%+43.9% a yearPrice +182.0% |
| 5 years since November 15, 2021 | +106.9%+15.6% a yearPrice +40.4% | +226.1%+26.7% a yearPrice +190.5% |
| 10 years since November 17, 2016 | +115.3%+8.0% a yearPrice -3.4% | +455.6%+18.7% a yearPrice +294.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
SBRASabra Health Care REITWELLWelltower
| Price | $20.35 | $244.65 |
|---|---|---|
| Market value | $5.1B | $179B |
| Enterprise value (EV) | $7.5B | – |
| P/E | 71.8 | 107.7 |
| P/E, 5-year median | – | – |
| P/B | 1.8 | 3.7 |
| EV/EBIT | 115.8 | – |
| Free cash flow yield | – | 1.2% |
| Revenue, 12 months | $919M | $13.8B |
|---|---|---|
| Net income, 12 months | $72M | $1.7B |
| Free cash flow, 12 months | – | $2.1B |
| Earnings per share, 12 months | $0.28 | $2.30 |
| Revenue growth, year on year | 10.2% | 35.6% |
| Revenue growth a year, past | +5.3%over 5 years | +18.7%over 5 years |
| EPS growth a year, past | -0.9%over 5 years | -9.8%over 5 years |
| Gross margin | – | 39.2% |
|---|---|---|
| Operating margin | – | – |
| Net margin | 7.8% | 12.1% |
| ROIC | 1.0% | – |
| ROE | 2.6% | 3.8% |
| Cash | $36M | $2.3B |
|---|---|---|
| Total debt | $2.4B | $20.1B |
| Net debt / EBITDA | 9.5 | – |
| Interest cover | 0.6× | – |
| Dividend yield | 5.9% | 1.3% |
|---|---|---|
| Dividend per share, 12 months | $1.20 | $3.18 |
| Dividend growth a year, past | -2.3%over 5 years | +0.9%over 5 years |
| Buyback yield | – | – |
| Shareholder yield | 5.9% | 1.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Welltower ($179B) is about 35.0 times Sabra Health Care REIT ($5.1B), at today's prices.
Since November 17, 2016, SBRA's price moved -3.4% and WELL's +294.7%. With dividends: SBRA +115.3% (+8.0% a year), WELL +455.6% (+18.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is 5.90% for Sabra Health Care REIT and 1.30% for Welltower. Over the last twelve months they paid $1.20 and $3.18 per share.
At today's price, the P/E is 71.8 for SBRA and 107.7 for WELL. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 7.8% for Sabra Health Care REIT and 12.1% for Welltower, and the operating margin – and –. Revenue was $919M and $13.8B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.